Cargando…
Lung cancer in never smokers from the Princess Margaret Cancer Centre
INTRODUCTION: Lung cancer in never smokers represents a distinct epidemiological, clinical, and molecular entity. RESULTS: Most 712 never smoking lung cancer patients were female (72%) with a median age at diagnosis of 62.2 years (18–94). Caucasians (46%), East Asians (42%), adenocarcinoma histology...
Autores principales: | Korpanty, Grzegorz J., Kamel-Reid, Suzanne, Pintilie, Melania, Hwang, David M., Zer, Alona, Liu, Geoffrey, Leighl, Natasha B., Feld, Ronald, Siu, Lillian L., Bedard, Philippe L., Tsao, Ming-Sound, Shepherd, Frances A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5978248/ https://www.ncbi.nlm.nih.gov/pubmed/29854298 http://dx.doi.org/10.18632/oncotarget.25176 |
Ejemplares similares
-
Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trial
por: Stockley, Tracy L., et al.
Publicado: (2016) -
FOLFIRINOX for advanced pancreatic cancer: the Princess Margaret Cancer Centre experience
por: Chllamma, Muralidharan K, et al.
Publicado: (2016) -
Barriers in phase I cancer clinical trials referrals and enrollment: five-year experience at the Princess Margaret Hospital
por: Ho, Jeremy, et al.
Publicado: (2006) -
Lung cancer risk in never-smokers: a population-based case-control study of epidemiologic risk factors
por: Brenner, Darren R, et al.
Publicado: (2010) -
1777. Implementation of an Antimicrobial Stewardship Program (ASP) at the Princess Margaret Hospital, Nassau Bahamas
por: Johnson-Thompson, Valencia, et al.
Publicado: (2018)